These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 30651070)

  • 61. Safety of Monitoring Viral and Liver Function Markers in Patients With Prior Resolved Hepatitis B Infection After Kidney Transplantation.
    Maekawa H; Yazawa M; Koitabashi K; Imai N; Kawarazaki H; Nakazawa R; Sasaki H; Chikaraishi T; Shibagaki Y
    Transplant Proc; 2016; 48(6):2046-9. PubMed ID: 27569942
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Hepatitis B virus reactivation during belatacept treatment after kidney transplantation.
    Cambier ML; Canestri A; Lependeven C; Peltier J; Mesnard L; Dahan K
    Transpl Infect Dis; 2019 Dec; 21(6):e13170. PubMed ID: 31505095
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hepatitis B serological changes following allogeneic bone marrow transplantation.
    Teh BW; Slavin MA; Szer J; Sasadeusz JJ
    Transpl Infect Dis; 2013 Feb; 15(1):98-103. PubMed ID: 22783885
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Management of patients with overt or resolved hepatitis B virus infection undergoing rituximab therapy.
    Viganò M; Mangia G; Lampertico P
    Expert Opin Biol Ther; 2014 Jul; 14(7):1019-31. PubMed ID: 24909454
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Hepatitis B virus reactivation in kidney transplant patients with resolved hepatitis B virus infection: Risk factors and the safety and efficacy of preemptive therapy.
    Mei T; Noguchi H; Hisadome Y; Kaku K; Nishiki T; Okabe Y; Nakamura M
    Transpl Infect Dis; 2020 Apr; 22(2):e13234. PubMed ID: 31856328
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Determining Whether Prophylactic Antiviral Treatment Is Necessary in HBsAg-Negative/HBcAb-Positive Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Zhang A; Wu Y; Tan Y; Shi J; Zhao Y; Hu Y; Yu J; Zheng W; Lai X; Zhang M; Zhu Y; Ye Y; Huang Y; Fu S; Huang H; Luo Y
    Biol Blood Marrow Transplant; 2020 May; 26(5):956-964. PubMed ID: 31962163
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Clinical and virological factors associated with hepatitis B virus reactivation in HBsAg-negative and anti-HBc antibodies-positive patients undergoing chemotherapy and/or autologous stem cell transplantation for cancer.
    Borentain P; Colson P; Coso D; Bories E; Charbonnier A; Stoppa AM; Auran T; Loundou A; Motte A; Ressiot E; Norguet E; Chabannon C; Bouabdallah R; Tamalet C; Gérolami R
    J Viral Hepat; 2010 Nov; 17(11):807-15. PubMed ID: 20002298
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient.
    Awerkiew S; Däumer M; Reiser M; Wend UC; Pfister H; Kaiser R; Willems WR; Gerlich WH
    J Clin Virol; 2007 Jan; 38(1):83-6. PubMed ID: 17134939
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prevention of Hepatitis B reactivation in the setting of immunosuppression.
    Pattullo V
    Clin Mol Hepatol; 2016 Jun; 22(2):219-37. PubMed ID: 27291888
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Reactivation of occult HBV infection in an HIV/HCV Co-infected patient successfully treated with sofosbuvir/ledipasvir: a case report and review of the literature.
    Fabbri G; Mastrorosa I; Vergori A; Mazzotta V; Pinnetti C; Grisetti S; Zaccarelli M; Ammassari A; Antinori A
    BMC Infect Dis; 2017 Mar; 17(1):182. PubMed ID: 28249574
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
    Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
    Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Reactivation of hepatitis B virus without core antibody.
    Silva-Pinto A; Andrade J; Araújo F; Santos L; Sarmento A
    J Clin Microbiol; 2015 Apr; 53(4):1434-5. PubMed ID: 25631798
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Fatal hepatitis B reactivation treated with entecavir in an isolated anti-HBs positive lymphoma patient: a case report and literature review.
    Ferreira R; Carvalheiro J; Torres J; Fernandes A; Giestas S; Mendes S; Agostinho C; Campos MJ
    Saudi J Gastroenterol; 2012; 18(4):277-81. PubMed ID: 22824772
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [The influence of hepatitis B virus infection on patients undergoing allogeneic hematopoietic stem cell transplantation].
    Liang C; Jiang EL; Huang Y; Yan ZS; Yang DL; He Y; Ma QL; Wei JL; Wang M; Feng SZ; Qiu LG; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2010 Jul; 31(7):456-60. PubMed ID: 21122399
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Hepatitis B reactivation in patients with previous hepatitis B virus exposure undergoing rituximab-containing chemotherapy for lymphoma: a prospective study.
    Seto WK; Chan TS; Hwang YY; Wong DK; Fung J; Liu KS; Gill H; Lam YF; Lie AK; Lai CL; Kwong YL; Yuen MF
    J Clin Oncol; 2014 Nov; 32(33):3736-43. PubMed ID: 25287829
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hepatitis B virus (HBV) reactivation in rheumatic patients with hepatitis core antigen (HBV occult carriers) undergoing anti-tumor necrosis factor therapy.
    Lee YH; Bae SC; Song GG
    Clin Exp Rheumatol; 2013; 31(1):118-21. PubMed ID: 23111095
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Reactivation of Hepatitis B Virus Infection With Reverse Seroconversion Following Umbilical Cord Allogeneic Hematopoietic Cell Transplantation in a Hepatitis-B-Immune Patient: A Case Report.
    Singh D; Hassan M; Lim N
    Transplant Proc; 2019 Mar; 51(2):602-604. PubMed ID: 30879599
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Extended lamivudine therapy against hepatitis B virus infection in hematopoietic stem cell transplant recipients.
    Hsiao LT; Chiou TJ; Liu JH; Chu CJ; Lin YC; Chao TC; Wang WS; Yen CC; Yang MH; Tzeng CH; Chen PM
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):84-94. PubMed ID: 16399572
    [TBL] [Abstract][Full Text] [Related]  

  • 80. High-titer antibody to hepatitis B surface antigen before liver transplantation can prevent de novo hepatitis B infection.
    Su WJ; Ho MC; Ni YH; Chen HL; Hu RH; Wu YM; Chang MH; Lee PH
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):203-8. PubMed ID: 19179883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.